Scientific Communication Platform Excellence

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Biotech; Health Care; Consumer Products; Communications; Laboratories


Companies Profiled:
Alkermes; Astellas; AstraZeneca; BELLUS Health; Boehringer Ingelheim; GlaxoSmithKline ; Gossamer Bio; Incyte; Ipsen; Merck; Nobel Biocare; Novartis; Novo Nordisk; OPEN Health; Oxford PharmaGenesis; Pfizer; Pierre Fabre; Sandoz; Spark Therapeutics; Torrent Pharmaceuticals Ltd.; UniQure

Study Snapshot

Best Practices, LLC engaged 21 Medical leaders from 21 pharma companies in this research through a benchmarking survey. Data in this research is further segmented by mid-small vs. large companies to provide in-depth insights.

Key topics covered in this report include:

• Development of Scientific Communication Platforms
• Format and Location of Scientific Communication Platforms
• Timing of Scientific Communication Platform Updates
• Effectiveness and Faults of Scientific Communication Platforms
• Scientific Communication Platform Maintenance and Operations
• Access and Utilization of Scientific Communication Platforms
• Best Practices and Pitfalls for SCP Implementation

• SCP Development: Medical Communications/Publications lead SCP development for 71% of participants; the same holds true for a majority of both Large and Mid-Small segments.

• SCP Utilization: SCP utilization is measured by a majority (61%) through level of incorporation into reactive and proactive materials for FMTs. Large Pharma particularly use this measure (88%) vs. 36% for Mid-Small (of which 36% do not measure).

• Function(s) leading the development of scientific communication platforms (SCP) – Total benchmark class
• Function(s) leading the development of scientific communication platforms (SCP) – Mid-small companies vs. Large companies
• Approach taken for SCP development – Total benchmark class
• Approach taken for SCP development – Mid-small companies vs. Large companies
• Medical group(s) that support the development of scientific communication platforms – Total benchmark class
• Medical group(s) that support the development of scientific communication platforms – Mid-small companies vs. Large companies
• Functional involvement in the approval of scientific communication platforms – Total benchmark class
• Functional involvement in the approval of scientific communication platforms – Mid-small companies vs. Large companies
• Timing for initial development of SCPs – Total benchmark class
• Timing for initial development of SCPs – Mid-small companies vs. Large companies
• Frequency of SCP development within benchmarked companies – Total benchmark class
• Frequency of SCP development within benchmarked companies – Mid-small companies vs. Large companies

• SCP format utilized by benchmark Medical teams – Total benchmark class
• SCP format utilized by benchmark Medical teams – Mid-small companies vs. Large companies
• Location of scientific communication platforms within benchmark companies – Total benchmark class
• Location of scientific communication platforms within benchmark companies – Mid-small companies vs. Large companies
• Desired information in the SCP – Total benchmark class
• Desired information in the SCP – Mid-small companies vs. Large companies
• Timing of SCP updates – Total benchmark class
• Timing of SCP updates – Mid-small companies vs. Large companies

• Effectiveness of scientific communication platforms – Total benchmark class
• Effectiveness of scientific communication platforms – Mid-small companies vs. Large companies
• Shortcomings of SCPs within benchmark companies

• Medical group that leads SCP maintenance – Total benchmark class
• Medical group that leads SCP maintenance – Mid-small companies vs. Large companies
• Presence of a dedicated Medical SCP Operations position within benchmark companies – Total benchmark class
• Presence of a dedicated Medical SCP Operations position within benchmark companies – Mid-small companies vs. Large companies

• Functions with access to scientific communication platforms – Total benchmark class
• Functions with access to scientific communication platforms – Mid-small companies vs. Large companies
• Metrics used to measure the internal access of SCPs – Total benchmark class
• Metrics used to measure the internal access of SCPs – Mid-small companies vs. Large companies
• Assessing the utilization of scientific communication platforms internally – Total benchmark class
• Assessing the utilization of scientific communication platforms internally – Mid-small companies vs. Large companies

• Interview narrative around scientific communications platforms being the key foundation for effective communication
• Top strategies recommended for successful SCP implementation
• Pitfalls observed during SCP initiation/development